SurmodicsSRDX
About: Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Employees: 389
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0.69% less ownership
Funds ownership: 82.77% [Q1] → 82.08% (-0.69%) [Q2]
4% less capital invested
Capital invested by funds: $361M [Q1] → $349M (-$12.7M) [Q2]
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
2% less funds holding
Funds holding: 134 [Q1] → 131 (-3) [Q2]
13% less call options, than puts
Call options by funds: $2.38M | Put options by funds: $2.75M
30% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 50
Research analyst outlook
We haven’t received any recent analyst ratings for SRDX.
Financial journalist opinion
Based on 6 articles about SRDX published over the past 30 days
